UPDATE 1-FDA halts trials of Amgen drug in children, cites death
February 26, 2013 at 13:10 PM EST
Feb 26 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it has stopped all pediatric clinical trials of Amgen Inc's Sensipar after the death of a 14-year-old patient taking part in a study of the drug.
